TY - JOUR
T1 - Personalized medicine. Closing the gap between knowledge and clinical practice
AU - Anaya, Juan Manuel
AU - Duarte-Rey, Carolina
AU - Sarmiento-Monroy, Juan C.
AU - Bardey, David
AU - Castiblanco, John
AU - Rojas-Villarraga, Adriana
N1 - Funding Information:
This work was supported by the School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
Publisher Copyright:
© 2016 Elsevier B.V.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Personalized medicine encompasses a broad and evolving field informed by a patient distinctive information and biomarker profile. Although terminology is evolving and some semantic interpretations exist (e.g., personalized, individualized, precision), in a broad sense personalized medicine can be coined as: “To practice medicine as it once used to be in the past using the current biotechnological tools.” A humanized approach to personalized medicine would offer the possibility of exploiting systems biology and its concept of P5 medicine, where predictive factors for developing a disease should be examined within populations in order to establish preventive measures on at-risk individuals, for whom healthcare should be personalized and participatory. Herein, the process of personalized medicine is presented together with the options that can be offered in health care systems with limited resources for diseases like rheumatoid arthritis and type 1 diabetes.
AB - Personalized medicine encompasses a broad and evolving field informed by a patient distinctive information and biomarker profile. Although terminology is evolving and some semantic interpretations exist (e.g., personalized, individualized, precision), in a broad sense personalized medicine can be coined as: “To practice medicine as it once used to be in the past using the current biotechnological tools.” A humanized approach to personalized medicine would offer the possibility of exploiting systems biology and its concept of P5 medicine, where predictive factors for developing a disease should be examined within populations in order to establish preventive measures on at-risk individuals, for whom healthcare should be personalized and participatory. Herein, the process of personalized medicine is presented together with the options that can be offered in health care systems with limited resources for diseases like rheumatoid arthritis and type 1 diabetes.
UR - http://www.scopus.com/inward/record.url?scp=84979266578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979266578&partnerID=8YFLogxK
U2 - 10.1016/j.autrev.2016.06.005
DO - 10.1016/j.autrev.2016.06.005
M3 - Review article
C2 - 27302209
AN - SCOPUS:84979266578
SN - 1568-9972
VL - 15
SP - 833
EP - 842
JO - Autoimmunity Reviews
JF - Autoimmunity Reviews
IS - 8
ER -